Monday, June 06, 2011
Experimental Pfizer cancer pill may sharply boost survival of lung cancer patients
TRENTON, N.J. - New research shows a promising drug for advanced lung tumors with a certain genetic mutation appears to double survival over standard cancer drugs. The drug from Pfizer Inc....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment